Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

Author： Balaña Carmen   López-pousa Antonio   Berrocal Alfonso   Yaya-tur Ricardo   Herrero Ana   García Jose-luis   Martín-broto Javier   Benavides Manuel   Cerdá-nicolás Miguel   Ballester Rosa   Balart Josep   Capellades Jaume  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.70, Iss.3, 2004-12, pp. : 359-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

By Peereboom David   Shepard Dale   Ahluwalia Manmeet   Brewer Cathy   Agarwal Neeraj   Stevens Glen   Suh John   Toms Steven   Vogelbaum Michael   Weil Robert   Elson Paul   Barnett Gene  

Journal of Neuro-Oncology, Vol. 98, Iss. 1, 2010-05 ,pp. : 93-99

Springer Publishing Company

Access to resources Recommend Favorite

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

By Ardon Hilko   Gool Stefaan   Lopes Isabel   Maes Wim   Sciot Raf   Wilms Guido   Demaerel Philippe   Bijttebier Patricia   Claes Laurence   Goffin Jan   Calenbergh Frank   Vleeschouwer Steven  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme

By Turner Christopher   Chi Susan   Marcus Karen   MacDonald Tobey   Packer Roger   Poussaint Tina   Vajapeyam Sridhar   Ullrich Nicole   Goumnerova Liliana   Scott R.   Briody Caitlin   Chordas Christine   Zimmerman Mary   Kieran Mark  

Journal of Neuro-Oncology, Vol. 82, Iss. 1, 2007-03 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Newly Diagnosed Glioblastoma with Concomitant and Adjuvant Temozolomide and Radiotherapy: UK Experience

By Beresford Mark J.   Power Danielle   Alexander Emma   Brock Cathryn   Thompson Julian   Roncaroli Federico   Waldman Adam D.   James van Dellen   Glaser Mark  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 427-432

Adis International

Access to resources Recommend Favorite